Key result
Transapical TAVI achieved similar adjusted quality of life compared with SAVR, as an initial difference in SF-36 physical health metascore disappeared after adjustment.
Why the study?
Does transcatheter aortic valve implantation via transapical access improve health-related quality of life compared to surgical aortic valve replacement in high-risk patients?
Cohort (n=144)
Does transcatheter aortic valve implantation via transapical access improve health-related quality of life compared to surgical aortic valve replacement in high-risk patients?
In high-risk patients, transapical TAVI achieves similar clinical outcomes and quality of life compared to surgical aortic valve replacement, with higher STS scores predicting worse QoL outcomes.
Answers are grounded in this paper and cite their sources.
Transapical TAVI was associated with similar adjusted quality of life versus SAVR; observational data leaves open confirmation in randomized trials.
OBJECTIVES: To compare health-related quality of life (QoL) in patients undergoing transcatheter aortic valve implantation via transapical access (TA TAVI) with patients undergoing surgical aortic valve replacement (SAVR). METHODS: One hundred and forty-four high-risk patients referred for aortic valve replacement underwent TAVI screening and were assigned to either TA TAVI (n = 51, age 79.7 ± 9.2 years, logistic EuroSCORE 26.5 ± 16.1%, 51% males) or SAVR (n = 93, age 81.1 ± 5.3 years, logistic EuroSCORE 12.1 ± 9.3%, 42% males) by the interdisciplinary heart team. QoL was assessed using the Short Form 36 (SF-36) Health Survey Questionnaire and the Hospital Anxiety and Depression Scale. Furthermore, current living conditions and the degree of independence at home were evaluated. RESULTS: Patients undergoing TA TAVI were at higher risk as assessed by EuroSCORE (26.5 ± 16 vs. 12.1 ± 9, P < 0.001) and STS score (6.7 ± 4 vs. 4.4 ± 3, P < 0.001) compared with SAVR patients. At the 30-day follow-up, the rate of mortality was similar and amounted to 7.8% for TA TAVI and 7.5% for SAVR patients and raised to 25.5% in TA TAVI and 18.3% in SAVR patients after a follow-up period of 15 ± 10 months. Assessment of QoL revealed no differences in terms of anxiety and depression between TA TAVI and SAVR patients. The SF-36 mental health metascore was similar in both groups (65.6 ± 19 vs. 68.8 ± 22, P = 0.29), while a significant difference was observed in the physical health metascore (49.7 ± 21 vs. 62.0 ± 21, P = 0.015). After adjustment for baseline characteristics, this difference disappeared. However, every added point in the preoperative risk assessment with the STS score decreased the SF-36 physical health dimension by two raw points at the follow-up assessment. CONCLUSIONS: Selected high-risk patients undergoing TAVI by using a transapical access achieve similar clinical outcomes and QoL compared with patients undergoing SAVR. Increased STS scores predict worse QoL outcomes.
No takes yet. Share an insight, caveat, or question.
Amonn et al. (2012) conducted a cohort in High-risk patients referred for aortic valve replacement (n=144). Transcatheter aortic valve implantation via transapical access (TA TAVI) vs. Surgical aortic valve replacement (SAVR) was evaluated on SF-36 physical health metascore (p=0.015). Transapical TAVI achieved similar adjusted quality of life compared with SAVR, as an initial difference in SF-36 physical health metascore disappeared after adjustment.
Synapse has enriched 10 related papers. Consider them for comparative context: